Researchers at Washington University School of Medicine in St. Louis developed a blood-test model that estimates when Alzheimer’s symptoms may begin. Published in Nature Medicine, the study shows plasma p-tau217 can predict symptom onset within three to four years — a promising step for faster, more targeted prevention trials.
Read more from the WashU Newsroom by clicking here.
